List of works by Petri Bono

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial

scientific article published on 02 March 2017

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial

article

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial

scientific article published on 2 November 2015

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial

scientific article published on 10 November 2009

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...

scientific article (publication date: December 2015)

Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma

scientific article

Correlation of c-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib.

scientific article published in February 2017

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

scientific article

Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial

scientific article published on 2 November 2009

Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma

scientific article published on 05 January 2011

Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy

article

Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression

scientific article published on 17 October 2005

Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance

scientific article published on 13 October 2009

Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).

scientific article published on 19 August 2013

Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma

scientific article

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

scientific article published on 6 September 2012

Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer

scientific article published on 05 June 2013

Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma

scientific article

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.

scientific article published in June 2008

p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial.

scientific article

Paulina is supported by:

About Paulina

Help